CCCC vs MSFT: Which Stock is Better?
Side-by-side comparison of C4 Therapeutics Inc and Microsoft Corp in 2026
CCCC
C4 Therapeutics Inc
$2.92
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | CCCC | MSFT | Winner |
|---|---|---|---|
| Market Cap | $282.98M | N/A | CCCC |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 1.1% | 0.2% | CCCC |
| Gross Margin | 75.0% | 68.6% | CCCC |
Analyze CCCC
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CCCC or MSFT a better investment?
Comparing CCCC and MSFT: C4 Therapeutics Inc has a market cap of $282.98M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CCCC and MSFT?
CCCC (C4 Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CCCC or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CCCC or MSFT?
CCCC has higher revenue growth at 1.1% vs 0.2% for MSFT.
Which company is more profitable: CCCC or MSFT?
C4 Therapeutics Inc (CCCC) has higher gross margins at 75.0% compared to 68.6% for MSFT.
Which is the larger company: CCCC or MSFT?
C4 Therapeutics Inc (CCCC) is larger with a market cap of $282.98M compared to N/A for MSFT.
Should I buy CCCC or MSFT in 2026?
Both CCCC and MSFT have investment merit. CCCC trades at $2.92 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CCCC and MSFT stock?
Key differences: Market Cap ($282.98M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (1.1% vs 0.2%), Gross Margin (75.0% vs 68.6%).